Different secretion patterns of two molecular forms of cardiac adrenomedullin in pressure- and volume-overloaded human heart failure

Journal of Cardiac Failure

Volumn 10, Issue 4, 2004, Pages 321-327

  Nishikimi, Toshio ^a   Asakawa, Hiroshi ^a   Iida, Hiroshi ^b   Matsushita, Yasushi ^b   Shibasaki, Ikuko ^b   Tadokoro, Kazuyoshi ^a   Mori, Yosuke ^a   Mori, Hideaki ^b   Mochizuki, Yoshihiko ^b   Okamura, Yoshitaka ^b   Miyoshi, Shinichiro ^b   Kangawa, Kenji ^b   Matsuoka, Hiroaki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b School of Medicine ^*

Author keywords

Adrenomedullin; Heart failure; Pericardial fluid; Plasma; Pressure overload; Valvular; Volume overload

Indexed keywords

ADRENOMEDULLIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART FAILURE; HEART VALVE REPLACEMENT; HEART VENTRICLE OVERLOAD; HEART VOLUME; HUMAN; IMMUNORADIOMETRIC ASSAY; MALE; MOLECULAR DYNAMICS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADRENOMEDULLIN; ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; BIOLOGICAL MARKERS; BLOOD PRESSURE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PEPTIDES; PERICARDIUM; STATISTICS; STROKE VOLUME; VENTRICULAR PRESSURE;

EID: 4143073676     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2003.12.002     Document Type: Article

References (36)

1. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Matsuo H., Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 192:1993;553-560
2. Owji A.A., Smith D.M., Coppock H.A., Morgan D.G., Bhogal R., Ghatei M.A., et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 136:1995;2127-2134
3. Nishikimi T., Horio T., Yoshihara F., Nagaya N., Matsuo H., Kangawa K. Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes. Eur J Pharmacol. 353:1998;337-344
4. Tsuruda T., Kato J., Kitamura K., Kuwasako K., Imamura T., Koiwaya Y., et al. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension. 31:1998;505-510
5. Horio T., Nishikimi T., Yoshihara F., Matsuo H., Takishita S., Kangawa K. Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts. Eur J Pharmacol. 382:1999;1-9
6. Tsuruda T., Kato J., Kitamura K., Kawamoto M., Kuwasako K., Imamura T., et al. An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth. Cardiovasc Res. 43:1999;958-967
7. Szokodi I., Kinnunen P., Tavi P., Weckstrom M., Toth M., Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation. 97:1998;1062-1070
8. Charles C.J., Rademaker M.T., Richards A.M., Cooper G.J., Coy D.H., Jing N.Y., et al. Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep. Am J Physiol Regul Integr Comp Physiol. 272:1997;R2040-R2047
9. Nishikimi T., Horio T., Sasaki T., Yoshihara F., Takishita S., Miyata A., et al. Cardiac production and secretion of adrenomedullin are increased in heart failure. Hypertension. 30:1997;1369-1375
10. Morimoto A., Nishikimi T., Yoshihara F., Horio T., Nagaya N., Matsuo H., et al. Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats. Hypertension. 33:1999;1146-1152
11. Romppanen H., Marttila M., Magga J., Vuolteenaho O., Kinnunen P., Szokodi I., et al. Adrenomedullin gene expression in the rat heart is stimulated by acute pressure overload: blunted effect in experimental hypertension. Endocrinology. 138:1997;2636-2639
12. Kitamura K., Kato J., Kawamoto M., Tanaka M., Chino N., Kangawa K., et al. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun. 244:1998;551-555
13. Nishikimi T., Matsuoka H., Shimada K., Matsuo H., Kangawa K. Production and clearance sites of two molecular forms of adrenomedullin in human plasma. Am J Hypertens. 13:2000;1032-1034
14. Nishikimi T., Tadokoro K., Mori Y., Wang X., Akimoto K., Yoshihara F., et al. Ventricular adrenomedullin system in the transition from LVH to heart failure in rats. Hypertension. 41:2003;512-518
15. Tadokoro K., Nishikimi T., Mori Y., Wang X., Akimoto K., Matsuoka H. Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension. Regul Pept. 112:2003;71-78
16. Iwakura A., Fujita M., Hasegawa K., Sawamura T., Nohara R., Sasayama S., et al. Pericardial fluid from patients with unstable angina induces vascular endothelial cell apoptosis. J Am Coll Cardiol. 35:2000;1785-1790
17. Tanaka T., Hasegawa K., Fujita M., Tamaki S.I., Yamazato A., Kihara Y., et al. Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction. J Am Coll Cardiol. 31:1998;399-403
18. Nishikimi T., Shibasaki I., Iida H., Asakawa H., Matsushita Y., Mori H., et al. Molecular forms of adrenomedullin in pericardial fluid and plasma in patients with ischaemic heart disease. Clin Sci. 102:2002;669-677
19. Ohta H., Tsuji T., Asai S., Sasakura K., Teraoka H., Kitamura K., et al. One-step direct assay for mature-type adrenomedullin with monoclonal antibodies. Clin Chem. 45:1999;244-251
20. Ohta H., Tsuji T., Asai S., Tanizaki S., Sasakura K., Teraoka H., et al. A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma. Clin Chim Acta. 87:1999;131-143
21. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 90:1994;195-203
22. Sossin W.S., Fisher J.M., Scheller R.H. Cellular and molecular biology of neuropeptide processing and packaging. Neuron. 2:1989;1407-1417
23. Cuttitta F. Peptide amidation: signature of bioactivity. Anat Rec. 236:1993;87-95
24. Merkler D.J. C-terminal aminated peptides: production by the in vitro enzymatic amidation of glycine-extended peptides and the importance of the amide to bioactivity. Enzyme Microb Technol. 16:1994;450-456
25. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun. 194:1993;720-727
26. Asakawa H., Nishikimi T., Suzuki T., Hara S., Tsubokou Y., Yagi H., et al. Elevation of two molecular forms of adrenomedullin in plasma and urine in patients with acute myocardial infarction treated with early coronary angioplasty. Clin Sci. 100:2001;117-126
27. Nishikimi T., Saito Y., Kitamura K., Ishimitsu T., Eto T., Kangawa K., et al. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol. 26:1995;1424-1431
28. Hirayama N., Kitamura K., Imamura T., Kato J., Koiwaya Y., Tsuji T., et al. Molecular forms of circulating adrenomedullin in patients with congestive heart failure. J Endocrinol. 160:1999;297-303
29. Nishikimi T., Horio T., Kohmoto Y., Yoshihara F., Nagaya N., Inenaga T., et al. Molecular forms of plasma and urinary adrenomedullin in normal, essential hypertension and chronic renal failure. J Hypertens. 19:2001;765-773
30. Nishikimi T., Nagata S., Sasaki T., Yoshihara F., Nagaya N., Horio T., et al. The active molecular form of plasma adrenomedullin is extracted in the pulmonary circulation in patients with mitral stenosis: possible role of adrenomedullin in pulmonary hypertension. Clin Sci. 100:2001;61-66
31. Nishikimi T., Kitamura K., Saito Y., Shimada K., Ishimitsu T., Takamiya M., et al. Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension. 24:1994;600-604
32. Charles C.J., Lainchbury J.G., Lewis L.K., Rademaker M.T., Richards A.M., Yandle T.G., et al. The role of adrenomedullin. Am J Hypertens. 12:1999;166-173
33. Yoshihara F., Nishikimi T., Horio T., Yutani C., Nagaya N., Matsuo H., Ohe T., et al. Ventricular adrenomedullin concentration is a sensitive biochemical marker for volume and pressure overload in rats. Am J Physiol Heart Circ Physiol. 278:2000;H633-H642
34. Wang X., Nishikimi T., Akimoto K., Tadokoro K., Mori Y., Minamino N. Upregulation of ligand, receptor system, and amidating activity of adrenomedullin in left ventricular hypertrophy of severely hypertensive rats: effects of angiotensin-converting enzyme inhibitors and diuretic. J Hypertens. 21:2003;1171-1181
35. Horio T., Nishikimi T., Yoshihara F., Matsuo H., Takishita S., Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension. 35:2000;19-24
36. Knowles J.W., Esposito G., Mao L., Hagaman J.R., Fox J.E., Smithies O., et al. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest. 107:2001;975-984